What's New
FTD in the News
AviadoBio Announces Completion of Second Cohort in ASPIRE-FTD Trial at AFTD Education Conference
Gene therapy company AviadoBio announced the completion of the second cohort of its phase 1/2 clinical trial…
Two Drugs Selected for Evaluation in Platform Trial for PSP
A pair of drugs has been selected for evaluation in a platform trial that aims to accelerate…
Study Evaluates PET Tracer and Explores How PSP Damages Brain Synapses
A study published in the journal Alzheimer’s & Dementia evaluates the potential utility of a novel PET…
Former Judge Gains Artistic Ability after PPA Diagnosis
A former judge in Folsom, Calif., has discovered a newfound talent for visual art following a diagnosis…
PPA Telehealth Intervention Gets Positive Results in Phase 2 Clinical Trial
A phase 2 clinical trial evaluating a telehealth therapy intervention for primary progressive aphasia (PPA) published positive…
AFTD Ambassador Spencer Cline Delivers Moving Keynote Address at Hope Rising
“We are not a product of what has happened to us. We have the power of choice.”…
Study Evaluates the Efficacy of Nasally Administered Hormone for Apathy in FTD
A study published in the journal The Lancet Neurology evaluates the efficacy of the hormone oxytocin as…
Hope Rising Benefit Raises Over $1.9 Million for AFTD’s Mission
Top row, L-R: Hope Rising MC Paula Zahn, Hope Rising Benefit Co-Chairs Joan Berlin and Anna Wintour,…
Review Article Explores Lived Experiences of Ceasing Driving Due to Young-Onset Dementia
A review article published in the journal BMC Geriatrics explores and summarizes the lived experiences of ceasing…
“Inside Edition” Highlights Upcoming Documentary About a Family’s FTD Journey
A recent episode of Inside Edition explores the experiences of the late Susan Suchan and her family…
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)